{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,2]],"date-time":"2025-11-02T09:05:27Z","timestamp":1762074327126,"version":"build-2065373602"},"reference-count":34,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,5,22]],"date-time":"2024-05-22T00:00:00Z","timestamp":1716336000000},"content-version":"vor","delay-in-days":448,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100003762","name":"Institut Pasteur","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003762","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bulletin de l'Acad\u00e9mie Nationale de M\u00e9decine"],"published-print":{"date-parts":[[2023,3]]},"DOI":"10.1016\/j.banm.2022.11.017","type":"journal-article","created":{"date-parts":[[2023,1,18]],"date-time":"2023-01-18T10:05:07Z","timestamp":1674036307000},"page":"287-294","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["La recherche fran\u00e7aise face aux maladies infectieuses \u00e9mergentes\u00a0: de REACTing \u00e0 l\u2019ANRS- maladies infectieuses \u00e9mergentes"],"prefix":"10.1016","volume":"207","author":[{"given":"J.F.","family":"Delfraissy","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.banm.2022.11.017_bib0175","first-page":"83","article-title":"La recherche scientifique comme r\u00e9ponse \u00e0 l\u2019\u00e9pid\u00e9mie de chikungunya \u00e0 la R\u00e9union et \u00e0 Mayotte","volume":"12","author":"Setbon","year":"2008","journal-title":"Virologie"},{"key":"10.1016\/j.banm.2022.11.017_bib0180","first-page":"3","article-title":"Recherches en situation d\u2019\u00e9mergence infectieuse: La r\u00e9ponse \u00e0 la crise se pr\u00e9pare dans l\u2019intercrise","volume":"16","author":"Murgue","year":"2012","journal-title":"Virologie"},{"key":"10.1016\/j.banm.2022.11.017_bib0185","doi-asserted-by":"crossref","first-page":"2183","DOI":"10.1016\/S0140-6736(16)30059-9","article-title":"REACTing: the French response to infectious disease crisis","volume":"387","author":"Delfraissy","year":"2016","journal-title":"Lancet"},{"key":"10.1016\/j.banm.2022.11.017_bib0190","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1371\/journal.pntd.0007327","article-title":"Prevalence of chronic chikungunya and associated risks factors in the french west indies (La martinique): a prospective cohort study","volume":"14","author":"Bertolotti","year":"2020","journal-title":"PLoS Negl Trop Dis"},{"key":"10.1016\/j.banm.2022.11.017_bib0195","doi-asserted-by":"crossref","first-page":"e1001967","DOI":"10.1371\/journal.pmed.1001967","article-title":"Experimental treatment with favipiravir for ebola virus disease (the JIKI Trial): a historically controlled, single-arm proof-of-concept trial in Guinea","volume":"13","author":"Sissoko","year":"2016","journal-title":"PLOS Med"},{"key":"10.1016\/j.banm.2022.11.017_bib0200","doi-asserted-by":"crossref","first-page":"1258","DOI":"10.1016\/S1473-3099(15)00344-8","article-title":"Drug assessment in the Ebola virus disease epidemic in West Africa","volume":"15","author":"Yazdanpanah","year":"2015","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.banm.2022.11.017_bib0205","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1016\/S1473-3099(16)30516-3","article-title":"Multidisciplinary assessment of post-Ebola sequelae in Guinea (Postebogui): an observational cohort study","volume":"17","author":"Etard","year":"2017","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.banm.2022.11.017_bib0210","doi-asserted-by":"crossref","first-page":"1448","DOI":"10.1056\/NEJMoa1604330","article-title":"A Randomized controlled trial of ZMapp for ebola virus infection","volume":"375","author":"PREVAIL Writing Group I.I","year":"2016","journal-title":"N Engl J Med"},{"key":"10.1016\/j.banm.2022.11.017_bib0215","doi-asserted-by":"crossref","first-page":"e1001967","DOI":"10.1371\/journal.pmed.1001967","article-title":"Experimental treatment with favipiravir for ebola virus disease (the JIKI Trial): a historically controlled, single-arm proof-of-concept trial in Guinea. Lipsitch M, editor","volume":"13","author":"Sissoko","year":"2016","journal-title":"PLOS Med"},{"key":"10.1016\/j.banm.2022.11.017_bib0220","doi-asserted-by":"crossref","first-page":"1599","DOI":"10.1093\/infdis\/jiz006","article-title":"Extensive serological survey of multiple african nonhuman primate species reveals low prevalence of immunoglobulin G Antibodies to 4\u00a0Ebola Virus Species","volume":"220","author":"Ayouba","year":"2019","journal-title":"J Infect Dis"},{"key":"10.1016\/j.banm.2022.11.017_bib0225","doi-asserted-by":"crossref","first-page":"1423","DOI":"10.1016\/S0140-6736(14)61734-7","article-title":"Randomised controlled trials for Ebola: practical and ethical issues","volume":"384","author":"Adebamowo","year":"2014","journal-title":"Lancet"},{"key":"10.1016\/j.banm.2022.11.017_bib0230","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1056\/NEJMoa1709481","article-title":"Pregnancy outcomes after ZIKA infection in french territories in the Americas","volume":"378","author":"Hoen","year":"2018","journal-title":"N Engl J Med"},{"key":"10.1016\/j.banm.2022.11.017_bib0235","doi-asserted-by":"crossref","first-page":"e59","DOI":"10.1016\/S1473-3099(18)30497-3","article-title":"Alliance ZIKA Consortium. Familiar barriers still unresolved a perspective on the Zika virus outbreak research response","volume":"19","author":"Koopmans","year":"2019","journal-title":"Lancet Infect Dis"},{"year":"2021","author":"Patrice","series-title":"La recherche en temps d\u2019\u00e9pid\u00e9mie, du SIDA au Covid: histoire de l\u2019ANRS","key":"10.1016\/j.banm.2022.11.017_bib0240"},{"key":"10.1016\/j.banm.2022.11.017_bib0245","doi-asserted-by":"crossref","first-page":"100278","DOI":"10.1016\/j.lanepe.2021.100278","article-title":"Impact of SARS-CoV-2\u00a0Delta variant on incubation, transmission settings and vaccine effectiveness: results from a nationwide case-control study in France","volume":"13","author":"Grant","year":"2022","journal-title":"Lancet Reg Health Eur"},{"key":"10.1016\/j.banm.2022.11.017_bib0250","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1038\/s41586-020-2558-4","article-title":"Hydroxychloroquine use against SARS-CoV-2\u00a0infection in non-human primates","volume":"585","author":"Maisonnasse","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.banm.2022.11.017_bib0255","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/S1473-3099(21)00485-0","article-title":"DisCoVeRy Study Group. Remdesivir plus standard of care versus standard of care alone for the treatment of patients admitted to hospital with COVID-19 (DisCoVeRy): a phase 3, randomised, controlled, open-label trial","volume":"22","author":"Ader","year":"2022","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.banm.2022.11.017_bib0260","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1056\/NEJMc2206711","article-title":"Immunogenicity and safety of beta-adjuvanted recombinant booster vaccine","volume":"387","author":"Launay","year":"2022","journal-title":"N Engl J Med"},{"key":"10.1016\/j.banm.2022.11.017_bib0265","doi-asserted-by":"crossref","first-page":"6025","DOI":"10.1038\/s41467-022-33801-z","article-title":"Clinical phenotypes and outcomes associated with\u00a0SARS-CoV-2\u00a0variant Omicron in critically ill French patients with COVID-19","volume":"13","author":"de Prost","year":"2022","journal-title":"Nat Commun"},{"unstructured":"Avis du Conseil Scientifique COVID-19\u00a0du 19\u00a0juillet 2022. \u201cVivre avec les variants. la pandemie n\u2019est pas terminee. Mieux anticiper\u201d.","key":"10.1016\/j.banm.2022.11.017_bib0270"},{"key":"10.1016\/j.banm.2022.11.017_bib0275","doi-asserted-by":"crossref","first-page":"101557","DOI":"10.1016\/j.tmaid.2020.101557","article-title":"Lassa fever clinical course and setting a standard of care for future randomized trials: a protocol for a cohort study of Lassa-infected patients in Nigeria (LASCOPE)","volume":"36","author":"Duvignaud","year":"2020","journal-title":"Travel Med Infect Dis"},{"key":"10.1016\/j.banm.2022.11.017_bib0280","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1371\/journal.pntd.0008223","article-title":"Study of usutu virus neuropathogenicity in mice and human cellular models","volume":"14","author":"Cl\u00e9","year":"2020","journal-title":"PLoS Negl Trop Dis"},{"key":"10.1016\/j.banm.2022.11.017_bib0285","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1371\/journal.pntd.0008251","article-title":"Human plague: an old scourge that needs new answers","volume":"14","author":"Vall\u00e8s","year":"2020","journal-title":"PLoS Negl Trop Dis"},{"key":"10.1016\/j.banm.2022.11.017_bib0290","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/j.medmal.2018.04.393","article-title":"Plague: bridging gaps towards better disease control","volume":"48","author":"D\u2019Ortenzio","year":"2018","journal-title":"Med Mal Infect"},{"key":"10.1016\/j.banm.2022.11.017_bib0295","first-page":"8","article-title":"Can we make human plague history? A call to action","volume":"4","author":"Baril","year":"2019","journal-title":"BMJ Glob Heal"},{"unstructured":"Avis du 20\u00a0octobre 2022\u00a0du Comit\u00e9 de veille et d\u2019anticipation des risques sanitaires (COVARS), sur la Covid-19.","key":"10.1016\/j.banm.2022.11.017_bib0300"},{"unstructured":"Document de r\u00e9f\u00e9rence interminist\u00e9riel sur la strat\u00e9gie nationale de r\u00e9silience dans le domaine de la d\u00e9fense et de la s\u00e9curit\u00e9 nationale, Secr\u00e9tariat de la d\u00e9fense et de la s\u00e9curit\u00e9 nationale.","key":"10.1016\/j.banm.2022.11.017_bib0305"},{"key":"10.1016\/j.banm.2022.11.017_bib0310","first-page":"703","volume":"205","author":"Migus","year":"2021","journal-title":"Bull Acad Natl Med"},{"unstructured":"Colloque de l\u2019Acad\u00e9mie nationale de m\u00e9decine. Refonder la recherche et l\u2019innovation au c\u0153ur des CHU. Communiqu\u00e9 de l\u2019Acad\u00e9mie nationale de m\u00e9decine. 20\u00a0septembre 2022.","key":"10.1016\/j.banm.2022.11.017_bib0315"},{"unstructured":"Transparence, \u00e9thique, d\u00e9ontologie, int\u00e9grit\u00e9: une recherche responsable m\u00eame en temps de pand\u00e9mie. Rapport d\u2019activit\u00e9 INSERM 2020; 16-18.","key":"10.1016\/j.banm.2022.11.017_bib0320"},{"unstructured":"Communiqu\u00e9 de Presse de l\u2019Acad\u00e9mie nationale de m\u00e9decine. De la Covid-19\u00a0\u00e0 la variole du singe, variation sur le th\u00e8me des zoonoses.","key":"10.1016\/j.banm.2022.11.017_bib0325"},{"key":"10.1016\/j.banm.2022.11.017_bib0330","article-title":"After two years of pandemic, translating one health into action is urgent","author":"Lefran\u00e7ois","year":"2022","journal-title":"Lancet"},{"key":"10.1016\/j.banm.2022.11.017_bib0170","doi-asserted-by":"crossref","DOI":"10.1056\/NEJMra2208860","article-title":"Monkeypox","volume":"387","author":"Gessain","year":"2022","journal-title":"N Engl J Med"},{"unstructured":"From public to private firms: magnitude and channels of RDS spillovers. Coll\u00e8ge de France. 2022","key":"10.1016\/j.banm.2022.11.017_bib0335"}],"container-title":["Bulletin de l'Acad\u00e9mie Nationale de M\u00e9decine"],"original-title":[],"language":"fr","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0001407923000341?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0001407923000341?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,2]],"date-time":"2025-11-02T09:00:27Z","timestamp":1762074027000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0001407923000341"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,3]]},"references-count":34,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2023,3]]}},"alternative-id":["S0001407923000341"],"URL":"https:\/\/doi.org\/10.1016\/j.banm.2022.11.017","relation":{},"ISSN":["0001-4079"],"issn-type":[{"type":"print","value":"0001-4079"}],"subject":[],"published":{"date-parts":[[2023,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"La recherche fran\u00e7aise face aux maladies infectieuses \u00e9mergentes\u00a0: de REACTing \u00e0 l\u2019ANRS- maladies infectieuses \u00e9mergentes","name":"articletitle","label":"Article Title"},{"value":"Bulletin de l'Acad\u00e9mie Nationale de M\u00e9decine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.banm.2022.11.017","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Published by Elsevier Masson SAS on behalf of l'Acad\u00e9mie nationale de m\u00e9decine.","name":"copyright","label":"Copyright"}]}}